FDA, NCL Launch “Take With Care” OTC Analgesic Safety Campaign
This article was originally published in The Tan Sheet
FDA is "very seriously" looking into labeling changes for OTC pain relievers, according to outgoing Associate Commissioner for External Relations Peter Pitts
You may also be interested in...
Wyeth Consumer Healthcare will revise labeling for two of its analgesic products to include more explicit warnings following FDA approval on Aug. 30
Recent edgy Tylenol promotions, which contrast sharply with previous traditional ads, reflect a dramatic change in marketing that coincides with McNeil Consumer & Specialty Pharmaceuticals' decision to switch ad agencies last year
Use of a "black box" warning on OTC acetaminophen labeling would be an inappropriate means for alerting consumers about potential liver damage, two consultants to FDA's Nonprescription Drugs Advisory Committee said Sept. 19